Rally Highlights Stakes for Illinois Families if 340B Protections Stall

BEVERLY -- Health advocates from across Chicago gathered in North Lawndale this week to urge lawmakers to finish the job on legislation protecting the 340B Drug Pricing Program—warning that failure to act would ripple far beyond the city’s West Side.

House Bill 2371 would prevent pharmaceutical manufacturers from interfering with community health centers and safety-net hospitals’ access to discounted medications. Supporters say the bill is essential for providers serving families throughout Chicago and across Illinois.

Dr. James Brooks of Lawndale Christian Health Center opened the rally by emphasizing unity among healthcare leaders. “We are in this fight together,” Brooks said, urging House leadership to move the bill forward immediately.

Speakers warned that upcoming Medicaid cuts will increase reliance on 340B savings to keep clinics open and medications affordable. Without those protections, Brooks cautioned, providers may be forced to scale back services—impacting patients statewide.

Patient advocate Chelsea Johnson personalized the issue, sharing her experience managing cancer and chronic illness. “Without the 340B program, affording my medications would be a serious challenge,” she said, stressing that the legislation has life-or-death consequences.

Mahomed Ouedraogo of ACCESS Community Health Network described how 340B supports care for 150,000 patients annually, many struggling with rising living costs. “It’s really about those decisions our patients have to make every single day,” he said.

State Rep. Anna Moeller highlighted the bill’s bipartisan support and its cost-neutral nature. “340B costs nothing to taxpayers,” she said. “The consequences of inaction are very real.”

Advocates say suburban and city communities alike depend on a stable healthcare safety net—and that protecting 340B is critical to keeping that system intact statewide.